Drug price regulation under consumer moral hazard
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Jerry A. Hausman & Jeffrey K. MacKie-Mason, 1988. "Price Discrimination and Patent Policy," RAND Journal of Economics, The RAND Corporation, vol. 19(2), pages 253-265, Summer.
- Feldstein, Martin S, 1973. "The Welfare Loss of Excess Health Insurance," Journal of Political Economy, University of Chicago Press, vol. 81(2), pages 251-280, Part I, M.
CitationsCitations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
- Juan Pablo Herrera Saavedra & Natalia Cantor Vargas & Jenny Paola Lis Gutiérrez & Jacobo Alberto Campo Robledo, 2014. "Discriminación de precios de segundo grado: el caso de tarifas multi-clase para el registro marcario en Colombia," REVISTA FACULTAD DE CIENCIAS ECONÓMICAS, UNIVERSIDAD MILITAR NUEVA GRANADA, vol. 0(1), pages 63-78, June.
More about this item
KeywordsOptimal drug pricing; Parallel imports; EU drug market;
StatisticsAccess and download statistics
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:eujhec:v:5:y:2004:i:4:p:324-329. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Sonal Shukla) or (Rebekah McClure). General contact details of provider: http://www.springer.com .